NeuropharmacologyAlzheimer DiseaseHumansWnt Signaling PathwayAnimalsbeta Catenin
The association of the Wnt/β-catenin signaling pathway with Alzheimer's disease.
JiaYing Ma, Yi Liu, Desheng Lu, Qi Sun
Published: 202610.1016/j.neuropharm.2025.110754
Abstract
With the global rise in population aging, the incidence of Alzheimer's disease (AD) continues to increase, posing a substantial burden on individuals, families, and healthcare systems. However, at present, the drugs approved by FDA for treating AD ca…
Preview only. Read the full abstract at the source